KIT and breast carcinoma: In several human tumors, including breast cancer, the SCF that triggers the c-kit signaling pathways has been described as possibly being involved in differentiation, migration, survival, and maturation of T-cells and other inflammatory cells into tumor sites, by a complex relation between mast cells, tumor cells, and T-lymphocytes in the tumor microenvironment [15, 16].